There is something the pharmaceutical industry can learn from this past year’s presidential election – social media counts. It’s no secret that the pharma industry is risk-averse. However, it’s time […]
There is something the pharmaceutical industry can learn from this past year’s presidential election – social media counts. It’s no secret that the pharma industry is risk-averse. However, it’s time […]